We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Collaborators to Develop Smart Consumables for a Novel Label-Free Biological Imaging System

By LabMedica International staff writers
Posted on 19 Dec 2011
A newly reported collaboration brings together the manufacturer of a novel system for biological image analysis and a large international developer and marketer of dedicated consumable products.

Maven Biotechnologies (Monrovia, CA, USA), manufacturer of the Label-Free Internal Reflection Ellipsometry (LFIRE) image analysis system has formally announced the establishment of a collaborative agreement with Sony DADC BioSciences (Salzburg, Austria), the biotech component of the international conglomerate Sony.

The basis of LFIRE is ellipsometry, a technique that measures changes in the polarization of light upon reflection from the interface between materials. More...
This measurement provides optical properties of thin layers of materials at the interface, namely the thickness or mass. Capable of detecting atom-scale changes in thickness or mass, ellipsometry is well established in the semiconductor industry for quality control analysis of silicon wafers.

LFIRE allows for the precise, real-time measurements of specific interactions between molecular entities in a microarray or well-plate format. These molecular entities can be proteins, nucleic acids, lipids, small molecules such as drugs or steroids, or even whole cells. As a “label-free” detection system, it avoids alterations of the molecules from the labeling procedures used in fluorescent systems and directly reduces labor and materials costs associated with tagging. As a “real-time” system, it monitors reactions as they happen, providing information about a sample before and after equilibrium. This additional information is necessary for increasing the dynamic range of concentration measurements, optimizing biological assays, and analyzing kinetic activity critical to drug research.

Sony intends to boost the market for the LFIRE system by contributing its experience in high-precision manufacturing as well as its mass production capability and supply chain expertise.

“The collaboration with Maven provides a perfect example of how we can translate our experience in microstructured engineering, gained through our pioneering optical disc work, to the needs of the life sciences industry,” said Dr. Ali Tinazli, a director of business development and sales at Sony DADC. “We are particularly pleased to work with Maven at such an early stage, which ensures solutions that will be scalable and traceable, to smooth the way to future regulatory approvals in the clinical space. The product is an advanced polymer slide that can be produced in mass quantities and still guarantee high optical quality.”

Jeffrey Chongsathien, chief engineering officer at Maven Biotechnologies, said, “We are excited to be working with Sony DADC to develop innovative consumables for our LFIRE platform. With Sony DADC's expertise in creating highly scalable and sophisticated optical media, we ensure that our customers will receive the maximum benefits of using LFIRE technology and at a lower cost per data point.”

Related Links:
Maven Biotechnologies
Sony DADC BioSciences




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.